Home

Tumeur maligne ampoule Imposition vas narasimhan salary Bord somme Le rasoir

Moderna CEO's Salary Spikes while the Median Employee's Falls | BioSpace
Moderna CEO's Salary Spikes while the Median Employee's Falls | BioSpace

How Much Novartis Pays Employees, From Scientists to Global Directors
How Much Novartis Pays Employees, From Scientists to Global Directors

99.1 Excerpts from Novartis Annual Report 2017
99.1 Excerpts from Novartis Annual Report 2017

Meet the 5 Indian-origin execs in Fortune's 40 Under 40 list
Meet the 5 Indian-origin execs in Fortune's 40 Under 40 list

Novartis Executive Salaries | Comparably
Novartis Executive Salaries | Comparably

Are you really worth a CHF 15 million salary, Mr. Schwan? - YouTube
Are you really worth a CHF 15 million salary, Mr. Schwan? - YouTube

Novartis chief's 2018 take-home pay suffers—not from Cohen but from  low-grade returns | Fierce Pharma
Novartis chief's 2018 take-home pay suffers—not from Cohen but from low-grade returns | Fierce Pharma

Meet the 5 Indian-origin execs in Fortune's 40 Under 40 list
Meet the 5 Indian-origin execs in Fortune's 40 Under 40 list

How Much Novartis Pays Employees, From Scientists to Global Directors
How Much Novartis Pays Employees, From Scientists to Global Directors

Vas Narasimhan (@VasNarasimhan) / Twitter
Vas Narasimhan (@VasNarasimhan) / Twitter

Latest - STAT
Latest - STAT

Novartis CEO: Cannabis not company focus despite Tilray partnership
Novartis CEO: Cannabis not company focus despite Tilray partnership

Watch We'll Be in a Solid Place Entering 2019, Says Novartis' CEO -  Bloomberg
Watch We'll Be in a Solid Place Entering 2019, Says Novartis' CEO - Bloomberg

Swiss Rival CEOs Take Home More than $12M Each in 2021 | BioSpace
Swiss Rival CEOs Take Home More than $12M Each in 2021 | BioSpace

Safir Adeni is Forbes Business Council Dallas-Ft.Worth Chair
Safir Adeni is Forbes Business Council Dallas-Ft.Worth Chair

Indian-origin Vasant Narasimhan to head $48 billion pharma giant Novartis |  Business Standard News
Indian-origin Vasant Narasimhan to head $48 billion pharma giant Novartis | Business Standard News

Narasimhan's Culture Club On Song At Novartis :: In Vivo
Narasimhan's Culture Club On Song At Novartis :: In Vivo

News: Indian-origin Vasant Narasimhan appointed as the new CEO of Novartis  — People Matters
News: Indian-origin Vasant Narasimhan appointed as the new CEO of Novartis — People Matters

Reimagining Novartis as a 'medicines and data science' company
Reimagining Novartis as a 'medicines and data science' company

20-F
20-F

99.1 Excerpts from Novartis Annual Report 2017
99.1 Excerpts from Novartis Annual Report 2017

Vas Narasimhan: the American trying to reshape Novartis | Financial Times
Vas Narasimhan: the American trying to reshape Novartis | Financial Times

Roche, Novartis CEOs pull down $12M-plus each in 2021 pay | Fierce Pharma
Roche, Novartis CEOs pull down $12M-plus each in 2021 pay | Fierce Pharma

How Much Novartis Pays Employees, From Scientists to Global Directors
How Much Novartis Pays Employees, From Scientists to Global Directors

novartis: Who is Vas Narasimhan? All about the new global chief executive  of Swiss pharma giant Novartis - The Economic Times
novartis: Who is Vas Narasimhan? All about the new global chief executive of Swiss pharma giant Novartis - The Economic Times

There's an explosion of data & digital opportunities in Indian healthcare: Vasant  Narasimhan, CEO, Novartis - The Economic Times
There's an explosion of data & digital opportunities in Indian healthcare: Vasant Narasimhan, CEO, Novartis - The Economic Times

Novartis CEO says Covid-related doctor visit delays likely impacting cancer  diagnosis rates
Novartis CEO says Covid-related doctor visit delays likely impacting cancer diagnosis rates

Novartis CEO Explains Un-Bossing Culture Shift
Novartis CEO Explains Un-Bossing Culture Shift

Novartis CEO Vas Narasimhan Requests Lower Bonus Over Zolgensma Controversy
Novartis CEO Vas Narasimhan Requests Lower Bonus Over Zolgensma Controversy